Baillie Gifford - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 54 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,070,000
-8.9%
436,5120.0%0.00%0.0%
Q4 2021$1,174,000
-46.3%
436,5120.0%0.00%0.0%
Q3 2021$2,187,000
-32.8%
436,5120.0%0.00%
-50.0%
Q2 2021$3,256,000
+49.0%
436,512
+17.3%
0.00%
+100.0%
Q1 2021$2,185,000
+24.9%
372,2610.0%0.00%0.0%
Q4 2020$1,749,000
+36.5%
372,2610.0%0.00%0.0%
Q3 2020$1,281,000372,2610.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 6,304,705$15,824,8100.09%
Virtus ETF Advisers LLC 55,763$139,9650.08%
VANCE WEALTH, INC. 39,266$98,5580.04%
CSS LLC/IL 266,514$668,9500.04%
SHELL ASSET MANAGEMENT CO 322,738$8100.03%
Steward Partners Investment Advisory, LLC 600,000$1,506,0000.02%
Alpine Global Management, LLC 30,000$75,3000.02%
SECTORAL ASSET MANAGEMENT INC 50,000$125,5000.02%
BENDER ROBERT & ASSOCIATES 24,059$60,3880.02%
HoyleCohen, LLC 74,408$186,7650.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders